Pantoprazole Aurobindo Pharma (Malta) Limited

Pantoprazole, the active ingredient in Pantoprazole Aurobindo Pharma (Malta) Limited, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and NSAID‑induced gastric ulcers in adult patients.

GNH USA supplies Pantoprazole Aurobindo Pharma (Malta) Limited as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery to healthcare institutions across Europe, the Middle East and Asia.

Pantoprazole is a proton pump inhibitor used to manage acid‑related disorders by decreasing gastric acid secretion.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining a higher gastric pH. - Erosive esophagitis: promotes healing of inflamed esophageal tissue through sustained acid suppression. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors. - NSAID‑induced gastric ulcer: reduces ulcer recurrence by limiting acid exposure to the gastric mucosa.

Pantoprazole may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild headache reported by some patients. - Diarrhea: transient loose stools. - Nausea: occasional feeling of stomach upset.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or breathing difficulty. - Clostridioides difficile infection: persistent watery diarrhea indicating colitis. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures.

When prescribing Pantoprazole, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: dose adjustment may be needed in severe renal impairment. - Evaluate for hepatitis B: monitor for reactivation in chronic carriers. - Use with caution in the elderly: higher incidence of fractures reported. - Avoid prolonged use without indication: long‑term therapy may increase risk of bone loss. - Monitor electrolytes: check magnesium and calcium levels periodically. - Store at room temperature: keep tablets in the original container, protect from moisture and light.

Pantoprazole can affect the pharmacokinetics of several co‑administered drugs, requiring attention to potential interactions.

Major Interactions (Avoid): - Ketoconazole: reduced absorption leading to loss of antifungal efficacy. - Atazanavir: markedly decreased plasma concentrations compromising HIV therapy. - Warfarin: enhanced anticoagulant effect increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels may require dose adjustment. - Methotrexate: higher exposure can exacerbate toxicity, especially at high doses. - Clopidogrel: diminished activation may reduce antiplatelet activity.